Figure 1
From: Potential role of LPAR5 gene in prognosis and immunity of thyroid papillary carcinoma and pan-cancer
Expression of LPAR5 in normal thyroid tissues and tumor tissues and six clinicopathological features of patients with PTC. (A) LPAR5 expression was significantly different in 58 normal tissues and 510 tumor tissues. (B) LPAR5 expression between the paired tumor tissues and normal tissues in the same sample. (C–E) The expression level of LPAR5 was significantly different in T stage, N stage, and stages I–IV. (F–H) The expression level of LPAR5 was not significantly different in age, gender, and M stage. [Figures created by R, version 4.1.3].
